Leaders in patient-centric clinical trials.

Learn About Our PI's

Leaders in Phase I-IV patient-centric clinical trials.

Abbas H. Mansour, MD

Principal Investigator, Easley, SC

Learn About Our PI's

Leaders in patient-centric clinical trials.

Learn About Our PI's

Leaders in Phase I-IV patient-centric clinical trials.

Gowdhami Mohan, MD

Principal Investigator, Anderson, SC

Learn About Our PI's

Leaders in patient-centric clinical trials.

Learn About Our PI's

Leaders in Phase I-IV patient-centric clinical trials.

Ravi Chandran, MD

Principal Investigator, Easley, SC

Learn About Our PI's

Leaders in patient-centric clinical trials.

Learn About Our PI's

Leaders in Phase I-IV patient-centric clinical trials.

Gregory Feldman, MD

Principal Investigator, Spartanburg, SC

Learn About Our PI's

Leaders in patient-centric clinical trials.

Learn About Our PI's

Leaders in Phase I-IV patient-centric clinical trials.

Farhan Sidiqqui, MD

Principal Investigator, Spartanburg, SC

Learn About Our PI's

Leaders in patient-centric clinical trials.

Learn About Our PI's

Leaders in Phase I-IV patient-centric clinical trials.

Luis Delacruz, MD

Principal Investigator, Union, SC

Learn About Our PI's

Leaders in patient-centric clinical trials.

Learn About Our PI's

Leaders in Phase I-IV patient-centric clinical trials.

Bang Giep, MD

Principal Investigator, Spartanburg, SC

Learn About Our PI's

Leaders in patient-centric clinical trials.

Learn About Our PI's

Leaders in Phase I-IV patient-centric clinical trials.

Joseph Boscia, MD

Principal Investigator, Spartanburg, SC

Learn About Our PI's

Leaders in patient-centric clinical trials.

Learn About Our PI's

Leaders in Phase I-IV patient-centric clinical trials.

David Godwin MD

Principal Investigator, Greenville, SC

Learn About Our PI's

Leaders in patient-centric clinical trials.

Learn About Our PI's

Leaders in Phase I-IV patient-centric clinical trials.

Rami Arfoosh, MD

Principal Investigator, Winder, GA

Learn About Our PI's

Leaders in patient-centric clinical trials.

Learn About Our PI's

Leaders in Phase I-IV patient-centric clinical trials.

Karen Devore, MD

Principal Investigator, Greenville, SC

Learn About Our PI's

Leaders in patient-centric clinical trials.

Learn About Our PI's

Leaders in Phase I-IV patient-centric clinical trials.

David Erb, MD

Principal Investigator, Gaffney, SC

Learn About Our PI's

Organized research. Strong outcomes.

VitaLink’s Fully Integrated Network of Clinical Trials Sites

connects renowned physicians and medical professionals with site managers and coordinators to create a seamless trial experience that puts the patient first and produces trustworthy and consistent results.

World Class Primary Investigators

THE VITALINK DIFFERENCE

World Class Primary Investigators

Our world-class Priniciple Investigators are at the heart of what sets VitaLink apart from other clinical trial networks. Our PIs are respected thought leaders with the common goal of advancing the clinical research field.

Learn About Our PI's

Case Studies

Holistically Standardized Processes

THE VITALINK DIFFERENCE

Holistically Standardized Processes

Consistent SOPs and quality control across all sites keeps information organized and accessible through one point of contact so testing can be completed ahead of schedule, on budget, and with reliable results.

Learn About Our Processes
7.9 Hours- SAE Turnaround Time

7.9 Hours

SAE Turnaround Time

11.6 Days- Regulatory Submission Time

11.6 Days

Regulatory Submission Time

13- Research sites

13

Research sites

2.6 day- Confidentiality Turnaround

2.6 day

Confidentiality Turnaround

27000- Research Subject Database

27000

Research Subject Database

113% Average- Enrollment vs. Promised

113% Average

Enrollment vs. Promised

4.46 Days- Contract Turn Around Time

4.46 Days

Contract Turn Around Time

58000- Patient Database

58000

Patient Database

0.7 Days- CDA Turn Around Time

0.7 Days

CDA Turn Around Time

4.2 Days- Enrollment Time (Green Light to FSFV)

4.2 Days

Enrollment Time (Green Light to FSFV)

100%- QC Rate

100%

QC Rate

3.05 Days- Feasibility Turn Around Time

3.05 Days

Feasibility Turn Around Time

See all metrics +Hide metrics -
The Patient-Centric Model Difference

THE VITALINK DIFFERENCE

The Patient-Centric Model Difference

Our patient’s well-being and safety takes precedence over all. VitaLink facilities are equipped with modern amenities and the comforts of home 
to create the best possible patient experience.

LEARN ABOUT OUR MODEL

News & Press

Top-Quality, Dedicated Research Sites

THE VITALINK DIFFERENCE

Top-Quality, Dedicated Research Sites

Our facilities are solely dedicated to clinical trials so we can consistently produce verifiable results. Our teams work collaboratively on state-of-the-art equipment to collect data with precision and timely execution.

LEARN ABOUT OUR SITES
astrazeneca
Asset 5
Chiltern
GSK
Quintiles
See all Clients +